Varicella Vaccine Dosing Recommendations

All individuals aged 12 months and older without evidence of immunity should receive two doses of varicella vaccine. 1

Standard Two-Dose Schedule by Age Group

First dose: Administer at 12-15 months of age 1, 2
Second dose: Administer at 4-6 years of age (before entering prekindergarten, kindergarten, or first grade) 1, 2
Minimum interval between doses: 3 months 1, 2
The second dose may be given earlier than 4-6 years, provided the minimum 3-month interval is maintained 1, 2
If the second dose is inadvertently administered between 28 days and 3 months after the first dose, it does not need to be repeated 2

Two doses required: Administer two 0.5 mL doses of single-antigen varicella vaccine 1
Minimum interval between doses: 4 weeks (28 days) 1, 2
Recommended interval: 4-8 weeks apart 1
Only single-antigen varicella vaccine may be used in this age group; MMRV is not licensed for persons ≥13 years 1, 2

All children, adolescents, and adults who previously received only one dose should receive a second dose 1
For children <12 years: Minimum 3-month interval between first and catch-up second dose 1
For persons ≥13 years: Minimum 4-week interval between first and catch-up second dose 1
The catch-up second dose may be administered at any interval longer than the minimum recommended interval 1

The two-dose schedule provides substantially superior protection compared to a single dose:

Vaccine efficacy: 98.3% with two doses versus 94.4% with one dose 1, 3
Breakthrough disease risk: Recipients of two doses are 3.3-fold less likely to develop breakthrough varicella compared to one-dose recipients 1, 2, 3
Antibody response: >99% of children achieve protective antibody levels after two doses, compared to only 76-85% after a single dose 2
Two doses provide 99.5% efficacy against moderate to severe varicella 4

Single-antigen varicella vaccine (Varivax): Approved for all persons ≥12 months, including adolescents and adults 2, 5
Combination MMRV vaccine (ProQuad): Approved only for children aged 12 months through 12 years 1, 2
Each dose is 0.5 mL administered subcutaneously 1, 2, 5

For the first dose in children aged 12-47 months, separate MMR and varicella vaccines are preferred over MMRV unless parents express preference for MMRV after discussing risks 2
MMRV carries approximately one additional febrile seizure per 2,300-2,600 doses compared to separate vaccines in children aged 12-23 months 2
For children ≥48 months, MMRV may be used without increased febrile seizure risk 2

Adults at increased risk who lack evidence of immunity should receive special consideration for two-dose vaccination 1:

All students at all grade levels (including college) should have received two doses of varicella vaccine or have other evidence of immunity 1
The high transmission risk in school settings necessitates this requirement 2

The 4-6 year timing for the second dose is strategically chosen because varicella incidence and outbreaks are higher among elementary school-aged children compared to preschool-aged children 1, 2
The 3-month minimum interval for children is based on the design of clinical trials evaluating two-dose regimens in this age group 1
Evidence suggests relatively high rates of primary vaccine failure (no initial response) rather than secondary failure (waning immunity), supporting the effectiveness of shorter intervals between doses 6